Modified Release Community

A reminder to everyone that the deadline for Programming Proposals for 2026 AAPS NBC is quickly approaching on Sep 26th.  See the announcement here: NBC - American Association of Pharmaceutical Scientists

As part of the Scientific Programming Committee leading "Track 1: Applying Translational Principles Across the Development Lifecycle" along with @Amritangshu Chakravarty, @Swetha Thiyagarajan, and @Joleen White, we would like to invite you to submit your programming proposals. Some focus areas of particular relevance to this group are:

• using artificial intelligence (AI) in formulation and manufacturing
• evaluating the safety of new excipients and adjuvants
• organoids, in silico, and in vitro models
• modality selection matched to disease and target
• delivering a drug to the site of action
• reverse translation to validate preclinical models
• evaluation of novel vectors including viral and lipid nanoparticles
• precision medicine
• prediction of patient response to different medication options

Please reach out with any questions! Looking forward to an amazing conference in San Diego next year

Dear Dr. Basiri,

Thank you for sharing this information with the MRC community. Several of the suggested focus areas are very relevant and of interest to our community. I encourage MRC community members to consider submitting a programming proposal to NBC. This is a great opportunity to showcase our ideas and contribute meaningfully to the broader dialogue. 

Submission Deadline: September 26, 2025

Cheers,

Sravan

Vice Chair, MRC

A reminder to everyone that the deadline for Programming Proposals for 2026 AAPS NBC is quickly approaching on Sep 26th.  See the announcement here: NBC - American Association of Pharmaceutical Scientists

As part of the Scientific Programming Committee leading "Track 1: Applying Translational Principles Across the Development Lifecycle" along with @Amritangshu Chakravarty, @Swetha Thiyagarajan, and @Joleen White, we would like to invite you to submit your programming proposals. Some focus areas of particular relevance to this group are:

• using artificial intelligence (AI) in formulation and manufacturing
• evaluating the safety of new excipients and adjuvants
• organoids, in silico, and in vitro models
• modality selection matched to disease and target
• delivering a drug to the site of action
• reverse translation to validate preclinical models
• evaluation of novel vectors including viral and lipid nanoparticles
• precision medicine
• prediction of patient response to different medication options

Please reach out with any questions! Looking forward to an amazing conference in San Diego next year